Women’s Health Newsflash: Stress & Breast Cancer Recurrence, Colon Cancer Screening, Caffeine & Painkillers, and a New Diet Drug
Who has time to stay on top of all the latest health news? Here are four recent headlines you need to know about:
Got Stress? It Could Impact Breast Cancer Recurrence
Excerpt: Women diagnosed with metastatic breast cancer who have also endured previous traumatic or stressful events see their cancer recur nearly twice as fast as other women, according to a report by a University of Rochester Medical Center scientist.
Possible Replacement Found for Common Colorectal Cancer Test
Excerpt: A new version of a colon cancer screening test effectively detects colorectal cancer and may be a good replacement for the test that is currently used, according to a study in the September 25 Journal of the National Cancer Institute.
Mixing Large Doses of Both Acetaminophen Painkiller and Caffeine May Increase Risk of Liver Damage
Excerpt: Consuming large amounts of caffeine while taking acetaminophen, one of the most widely used painkillers in the United States, could potentially cause liver damage, according to a preliminary laboratory study reported in the Oct. 15 print issue of ACS’ Chemical Research in Toxicology, a monthly journal. The toxic interaction could occur not only from drinking caffeinated beverages while taking the painkiller but also from using large amounts of medications that intentionally combine caffeine and acetaminophen for the treatment of migraine headaches, menstrual discomfort and other conditions, the researchers say.
Lively Women Note: Acetaminophen is the active ingredient in Tylenol. Other common over-the-counter or nonprescription pain relievers are ibuprofen (Advil) and naproxen (Aleve). These are known as nonsteriodal anti-inflammatory drugs, or NSAIDs.
Tel Aviv University Doctor Designs Weight-Loss Pill With Fewer Side Effects
Tags: acetaminophen, betahistine, Breast cancer, Caffeine, colorectal-cancer-test, diet-pill, histalean, liver-damage, metastatic, nir-barak, obecure, painkiller, recurrence, side-effects, Stress, tel-aviv-university, traumatic, University-of-Rochester-Medical-Center, weight-loss-pill, woman, women, Womens-HealthExcerpt: Dr. Nir Barak of Tel Aviv University’s Sackler School of Medicine has developed what could be a new weight-loss wonder drug. In conjunction with the drug company Obecure, Dr. Barak developed a new formulation called Histalean, based on betahistine, an approved drug marketed worldwide for the treatment of vertigo. Betahistine has been available to health authorities for over 30 years. Betahistine is believed to block receptors in the brain – the H1 and H3 receptors – which are connected to one’s sense of fullness and desire to eat fatty foods. It has an excellent safety profile and has been used for treatment by more than 100 million patients suffering from vertigo and dizziness in Canada and Europe. The repurposed pill, Histalean, has been found to quell the desire to consume fatty foods, and the effects have been most pronounced in women.
Related Stories
POSTED IN: Body, Cancer, Diet, Medicine, Medicines/medications, New research, Obesity, Stress, Weight Loss, Women's Health Newsflash, Women's Issues
.gif)
0 opinions for Women’s Health Newsflash: Stress & Breast Cancer Recurrence, Colon Cancer Screening, Caffeine & Painkillers, and a New Diet Drug
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: